About
Have you ever wished there was a source of information about Parkinson's Disease, and resources for persons with PD, that were concise and easy to digest? Look no further than the Parkinson's Disease Education Podcast. In this podcast we attempt to demystify the disease and to empower you to reach your true potential as a person with PD.
Creator
Dr. Michael Hyland, DPT, CEEAA
host
Reviews
Episodes(3)
Tavapadon and Parkinson's: A New Way to Stimulate Dopamine
Tavapadon is a new investigational medication for Parkinson's disease that works very differently from traditional dopamine agonists. Instead of broadly stimulating dopamine receptors, tavapadon selectively targets D1 receptors—the brain's primary "go" signal for movement—and does so as a partial ag
From Lab Bench to Brain: The Truth About Ivermectin and Parkinson's
In this episode ( watch on YouTube ) we examine recent lab and animal research suggesting ivermectin — a widely used antiparasitic — can alter striatal circuits and enhance L-DOPA responses in preclinical Parkinson's models. We'll explain the likely mechanisms (ion-channel modulation at P2X4 and nic
Prasinezumab Moves to Phase III — What That Means for Parkinson's Patients
Roche/Genentech announced on June 15–16, 2025 that prasinezumab — an anti-α-synuclein monoclonal antibody — will enter Phase III trials for early Parkinson's disease after mixed but encouraging Phase II signals. In this episode ( watch on YouTube ) we explain the biology behind α-synuclein targeting